[ Price : $8.95]
AnaptysBio reports positive data from a Phase 2 study of rosnilimab for treating moderate-to-severe rheumatoid arthritis.[ Price : $8.95]
Max Mobility recalls its Max Mobility/Permobil Smart Drive MX2+ SpeedControl Dial for wheelchair use due to a faulty circuit board...[ Price : $8.95]
FDA warns Mesquite, TX-based Strukmyer Medical about CGMP violations in manufacturing finished drugs and cosmetics.[ Price : $8.95]
FDA warns Chinas Chengdu Innovation Pharmaceutical Co. about CGMP deviations in manufacturing active pharmaceutical ingredients.[ Price : $8.95]
DC federal judge John Bates orders FDA and CDC to re-post Web pages and datasets they removed to comply with President Trumps exec...[ Price : $8.95]
A STAT First Opinion column calls on FDA to focus on how effective new antibiotics are in real-world patients, rather than approvi...[ Price : $8.95]
FDA accepts for priority review a Biohaven NDA for troriluzole for treating adult patients with spinocerebellar ataxia.[ Price : $8.95]
FDA grants Guerbet a Breakthrough Device Designation for LipioJoint, a liquid embolic agent designed to alleviate pain in patients...